Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori.
Hassan TariqHarish K PatelMuhammad Umar KamalNaeem AbbasMuhammad AmeenSara AzamKishore KumarMadhavi RaviVamshidhar VootlaDanial ShaikhVamsi AmanchiAli N HussainJasbir MakkerPublished in: Clinical and experimental gastroenterology (2020)
In conclusion, our study shows significantly lower eradication rates with Levofloxacin triple therapy among a selected US population. Thus, it may not be a good first-line therapy among this US population and the Clarithromycin based regimen may still be used successfully.